Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes

Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes

Abstract Background Mutations in the KEAP1-NFE2L2 signaling pathway were linked to increased tumorigenesis and aggressiveness. Interestingly, not all hotspot mutations on NFE2L2 were damaging; some even were activating. However, there was conflicting evidence about the association between NFE2L2 mut...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Kewei Wang, Zixi Li, Ying Xuan, Yong Zhao, Chao Deng, Meidan Wang, Chenjun Xie, Fenglai Yuan, Qingfeng Pang, Wenjun Mao, Dongyan Cai, Zhangfeng Zhong, Jie Mei
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMC 2023-10-01
Serie:	Cancer Cell International
Soggetti:	NFE2L2 NSCLC Biomarker NGS Immunotherapy
Accesso online:	https://doi.org/10.1186/s12935-023-03056-9

Documenti analoghi

Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
di: Shuo Yu, et al.
Pubblicazione: (2024-04-01)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
di: Mengxiao Liu, et al.
Pubblicazione: (2022-06-01)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
di: Guiyi Ji, et al.
Pubblicazione: (2021-05-01)

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
di: Kamila Łuczyńska, et al.
Pubblicazione: (2024-02-01)

The roles of NFE2L1 in adipocytes: Structural and mechanistic insight from cell and mouse models
di: Suping Ren, et al.
Pubblicazione: (2021-08-01)

Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling
di: Qiushi Xu, et al.
Pubblicazione: (2020-11-01)

Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma
di: Yuancai Xiang, et al.
Pubblicazione: (2024-03-01)

Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer
di: Haomeng Zhang, et al.
Pubblicazione: (2024-06-01)

Unravelling the role of NFE2L1 in stress responses and related diseases
di: Xingzhu Liu, et al.
Pubblicazione: (2023-09-01)

NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism
di: Jiao Liu, et al.
Pubblicazione: (2024-11-01)

A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
di: Chang Jiang, et al.
Pubblicazione: (2022-08-01)

Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases
di: Aswathy Chandran, et al.
Pubblicazione: (2023-08-01)

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
di: Mustafa Elshani, et al.
Pubblicazione: (2023-08-01)

NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers
di: Zhen Wang, et al.
Pubblicazione: (2022-05-01)

Multi-Omics Analysis of <i>NFE2L2</i>-Altered TCGA-Cervical Squamous Cell Carcinoma Patients
di: Sri Vidya Ramisetti, et al.
Pubblicazione: (2023-03-01)

Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice
di: Ang-Tse Lee, et al.
Pubblicazione: (2021-12-01)

Prevalence and Associations of Co-occurrence of <i>NFE2L2</i> Mutations and Chromosome 3q26 Amplification in Lung Cancer
di: Jinfeng Liu, et al.
Pubblicazione: (2024-06-01)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
di: Yue-chu Dai, et al.
Pubblicazione: (2021-12-01)

Impact of Genomic Variation of NFE2L2 (rs6706649) on Serum Glyoxalase-1 Levels in A Sample of Iraqi Type 2 Diabetic Patients with Retinopathy
di: Sarah Hashim Mhaibes, et al.
Pubblicazione: (2025-02-01)

New insight into the CNC-bZIP member, NFE2L3, in human diseases
di: Guanghui Xiong, et al.
Pubblicazione: (2024-07-01)

Single-nucleus RNA-sequencing reveals NRF1/NFE2L1 as a key factor determining the thermogenesis and cellular heterogeneity and dynamics of brown adipose tissues in mice
di: Wei Shen, et al.
Pubblicazione: (2023-11-01)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
di: Xing Jin, et al.
Pubblicazione: (2021-12-01)

NFE2/miR-423-5p/TFF1 axis regulates high glucose-induced apoptosis in retinal pigment epithelial cells
di: Qing Xiao, et al.
Pubblicazione: (2019-08-01)

Effects of Heat-Induced Oxidative Stress and Astaxanthin on the <i>NF-kB</i>, <i>NFE2L2</i> and <i>PPARα</i> Transcription Factors and Cytoprotective Capacity in the Thymus of Broilers
di: Donna Lee Kuehu, et al.
Pubblicazione: (2024-08-01)

LncRNA DLGAP1‐AS1 accelerates glioblastoma cell proliferation through targeting miR‐515‐5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway
di: Zixuan Wang, et al.
Pubblicazione: (2021-10-01)

Green Tea Polyphenols Alleviate Hydrogen Peroxide-Induced Oxidative Stress, Inflammation, and Apoptosis in Bovine Mammary Epithelial Cells by Activating ERK1/2–NFE2L2–HMOX1 Pathways
di: Yanfen Ma, et al.
Pubblicazione: (2022-01-01)

Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
di: John G. Witherspoon, et al.
Pubblicazione: (2024-09-01)

Carnosine Synthase (<i>Ts</i>ATPGD) Alleviates Lipid Peroxidation Under Transcriptional Control by an <i>Nfe2</i>-like Gene in <i>Tridacna Squamosa</i>
di: Zhuo Yang, et al.
Pubblicazione: (2024-11-01)

Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report
di: Rui Zhong, et al.
Pubblicazione: (2020-02-01)

Retracted: SLCO4A1‐AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR‐4701‐5p/NFE2L1 axis to activate WNT pathway
di: Yuxuan Wei, et al.
Pubblicazione: (2020-10-01)

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
di: Wenfeng Fang, et al.
Pubblicazione: (2019-06-01)

PEMBERIAN BEBERAPA DOSIS ENZIM PADA PAKAN KOMERSIAL TERHADAP KANDUNGAN SERAT KASAR, BAHAN ORGANIK DAN BETN
di: Pramono Kusuma Wardani, et al.
Pubblicazione: (2019-04-01)

Inhibiting nuclear factor erythroid 2 related factor 2-mediated autophagy in bovine mammary epithelial cells induces oxidative stress in response to exogenous fatty acids
di: Renxu Chang, et al.
Pubblicazione: (2022-04-01)

Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
di: Liam Baird, et al.
Pubblicazione: (2023-11-01)

mNFE: microbiome network flow entropy for detecting pre-disease states of type 1 diabetes
di: Rong Gao, et al.
Pubblicazione: (2024-12-01)

A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells
di: Liam Baird, et al.
Pubblicazione: (2023-10-01)

Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study
di: Shengyu Zhou, et al.
Pubblicazione: (2023-10-01)

Identification and verification of KEAP1‐related genes and targets regulated by potential ingredients in KRAS mutant colorectal cancer
di: Gang Wang, et al.
Pubblicazione: (2024-09-01)

Individual expression features of GPX2, NQO1 and SQSTM1 transcript variants induced by hydrogen peroxide treatment in HeLa cells
di: Anna A. Belanova, et al.
Pubblicazione: (2017-05-01)

Inhibition of microglial β-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons
di: Electra Brunialti, et al.
Pubblicazione: (2021-09-01)